Form D · Biotechnology
MaskZero LLC
Denver, CO · CIK 0001950454
Offering snapshot reported Dec 20, 2023 · SEC filing
- Reported sold
- $1.01M Offering amount: $1.5M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 30, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$245,000 → $1,010,000
- Reported investors4 → 15
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2023 | Amendment | $1,010,000 | $765,000vs Oct 12, 2022 | 15 | SEC filing |
| Oct 12, 2022 | Initial | $245,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-461545
Source: Form D, filed Dec 20, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Trevor Chandler | Director, Executive, Promoter |
| Adam Pener | Director, Executive, Promoter |
| Randy Roberts | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1550 Larimer Street Suite 634
Denver, CO, 80202
Denver, CO, 80202